References
1. Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors: D. Seiffert, et al.; J. Biol. Chem. 275: 34086 (2000). 2. Presenilin-dependent gamma-secretase activity modulates thymocyte development: P. Doerfler, et al.; PNAS 98: 9312 (2001). 3. Pharmacological knock-down of the presenilin 1 heterodimer by a novel gamma -secretase inhibitor: impli- cations for presenilin biology: D. Beher, et al.; J. Biol. Chem. 276: 45394 (2001). 4. gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase: C.Y. Ni, et al.; Science 294: 2179 (2001). 5. Regulated intramembrane proteolysis of the p75 neurotrophin receptor modulates its association with the TrkA receptor: K.M. Jung, et al.; J. Biol. Chem. 278: 42161 (2003). 6. Identification of a new presenilin-dependent zeta-cleavage site within the transmembrane domain of amyloid precursor protein: G. Zhao, et al.; J. Biol. Chem. 279: 50647 (2004). 7. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia: A.P. Weng, et al.; Science 306: 269 (2004) 8. Determination of guinea-pig cortical gamma-secretase activity ex vivo following the systemic administration of a gamma-secretase inhibitor: S. Grimwood, et al.; Neuropharmacology 48: 1002 (2005). 9. Jagged/Notch signalling is required for a subset of TGFbeta1 responses in human kidney epithelial cells: K.C. Nyhan, et al.; Biochim. Biophys. Acta 1803: 1386 (2010)USBio References
No references available